GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TherapeuticsMD Inc (NAS:TXMD) » Definitions » Cyclically Adjusted PB Ratio

TherapeuticsMD (TherapeuticsMD) Cyclically Adjusted PB Ratio : 0.14 (As of Apr. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is TherapeuticsMD Cyclically Adjusted PB Ratio?

As of today (2024-04-28), TherapeuticsMD's current share price is $1.86. TherapeuticsMD's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $13.64. TherapeuticsMD's Cyclically Adjusted PB Ratio for today is 0.14.

The historical rank and industry rank for TherapeuticsMD's Cyclically Adjusted PB Ratio or its related term are showing as below:

TXMD' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.14   Med: 1.15   Max: 19.77
Current: 0.14

During the past years, TherapeuticsMD's highest Cyclically Adjusted PB Ratio was 19.77. The lowest was 0.14. And the median was 1.15.

TXMD's Cyclically Adjusted PB Ratio is ranked better than
92.74% of 647 companies
in the Drug Manufacturers industry
Industry Median: 1.75 vs TXMD: 0.14

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

TherapeuticsMD's adjusted book value per share data for the three months ended in Dec. 2023 was $2.540. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $13.64 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


TherapeuticsMD Cyclically Adjusted PB Ratio Historical Data

The historical data trend for TherapeuticsMD's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TherapeuticsMD Cyclically Adjusted PB Ratio Chart

TherapeuticsMD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 12.52 1.22 0.37 0.16

TherapeuticsMD Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.25 0.28 0.21 0.16

Competitive Comparison of TherapeuticsMD's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, TherapeuticsMD's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TherapeuticsMD's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TherapeuticsMD's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where TherapeuticsMD's Cyclically Adjusted PB Ratio falls into.



TherapeuticsMD Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

TherapeuticsMD's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.86/13.64
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TherapeuticsMD's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, TherapeuticsMD's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.54/129.4194*129.4194
=2.540

Current CPI (Dec. 2023) = 129.4194.

TherapeuticsMD Quarterly Data

Book Value per Share CPI Adj_Book
201403 16.114 99.695 20.919
201406 12.843 100.560 16.529
201409 20.381 100.428 26.265
201412 15.500 99.070 20.248
201503 25.403 99.621 33.001
201506 18.206 100.684 23.402
201509 21.812 100.392 28.119
201512 17.721 99.792 22.982
201603 46.718 100.470 60.179
201606 42.559 101.688 54.165
201609 37.225 101.861 47.296
201612 32.409 101.863 41.177
201703 27.779 102.862 34.951
201706 22.936 103.349 28.722
201709 34.534 104.136 42.919
201712 30.012 104.011 37.343
201803 24.771 105.290 30.448
201806 17.881 106.317 21.767
201809 28.380 106.507 34.485
201812 20.278 105.998 24.759
201903 12.580 107.251 15.180
201906 1.678 108.070 2.010
201909 -4.399 108.329 -5.255
201912 1.696 108.420 2.024
202003 -8.320 108.902 -9.888
202006 -17.277 108.767 -20.557
202009 -21.266 109.815 -25.062
202012 -20.683 109.897 -24.357
202103 -1.205 111.754 -1.395
202106 -6.211 114.631 -7.012
202109 -6.750 115.734 -7.548
202112 -10.889 117.630 -11.980
202203 -16.216 121.301 -17.301
202206 -2.942 125.017 -3.046
202209 -5.099 125.227 -5.270
202212 3.700 125.222 3.824
202303 3.354 127.348 3.409
202306 2.950 128.729 2.966
202309 2.653 129.860 2.644
202312 2.540 129.419 2.540

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


TherapeuticsMD  (NAS:TXMD) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


TherapeuticsMD Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of TherapeuticsMD's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


TherapeuticsMD (TherapeuticsMD) Business Description

Traded in Other Exchanges
Address
951 Yamato Road, Suite 220, Boca Raton, FL, USA, 33431
TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.
Executives
Marlan D Walker officer: General Counsel 951 YAMATO ROAD, SUITE 220, BOCA RATON FL 33431
Joseph Ziegler officer: Principal Financial Officer 1051 HILLSBORO MILE, PH2, HILLSBORO BEACH FL 33062
Michael C Donegan officer: CAO and VP of Finance 6800 BROKEN SOUND PARKWAY NW, THIRD FLOOR, BOCA RATON FL 33487-3507
Rubric Capital Management Lp 10 percent owner 155 EAST 44TH ST, SUITE 1630, NEW YORK NY 10017
Brian Bernick director 951 BROKEN SOUND PARKWAY NW, SUITE 320, BOCA RATON FL 33487
Gail K Naughton director C. R. BARD, INC., 730 CENTRAL AVENUE, MURRAY HILL NJ 07974
Mark A Glickman officer: Chief Business Officer C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR MI 48108
Justin Hunter Roberts director C/O RUBRIC CAPTIAL MANAGEMENT LP, 155 EAST 44TH ST., SUITE 1630, NEW YORK NY 10017
Tommy G Thompson director 7711 CARONDELET, ST. LOUIS MO 63105
Karen Ling director C/O FOREST LABORATORIES, INC., 909 THIRD AVENUE, NEW YORK NY 10022
Paul Bisaro director
Angus C. Russell director C/O INTERMUNE, INC., 3280 BAYSHORE BOULEVARD, BRISBANE CA 94005
Jules A. Musing director 9 INNOVATION WAY, SUITE 100, NEWARK DE 19711
David Efraim Rosen 10 percent owner 155 EAST 44TH ST., SUITE 1630, NEW YORK NY 10017
Collins Cooper C. director 33219 FOREST WEST DRIVE, MAGNOLIA TX 77354

TherapeuticsMD (TherapeuticsMD) Headlines